Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

ClinicalTrials.gov ID: NCT05459688

Public ClinicalTrials.gov record NCT05459688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 to Evaluate the Long-Term Safety and Effectiveness of CIN-107

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, multicenter, open-label extension (OLE) study to evaluate the long-term safety, tolerability, and effectiveness of CIN-107 for up to 52 weeks in patients with HTN who have completed Part 1 or Part 2 of Study CIN-107-124. The study will be conducted at clinical sites that have participated in the double-blind, Phase 2 Study CIN-107-124.

Study identification

NCT ID
NCT05459688
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
175 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 5, 2022
Primary completion
Nov 6, 2023
Completion
Nov 6, 2023
Last update posted
Dec 15, 2024

2022 – 2023

United States locations

U.S. sites
36
U.S. states
14
U.S. cities
35
Facility City State ZIP Site status
Research Site Saraland Alabama 36571
Research Site Huntington Park California 90255
Research Site Lincoln California 95648
Research Site Los Angeles California 90057
Research Site Northridge California 91324
Research Site Oceanside California 92056
Research Site Panorama City California 91402
Research Site Van Nuys California 91405
Research Site Clearwater Florida 33765
Research Site Doral Florida 33166
Research Site Hialeah Florida 33012
Research Site Hollywood Florida 33024
Research Site Lake Worth Florida 33467
Research Site Miami Florida 33165
Research Site Miami Florida 33173
Research Site Pembroke Pines Florida 33027
Research Site Winter Haven Florida 33880
Research Site Addison Illinois 60101
Research Site Chicago Illinois 60607
Research Site Morton Illinois 61550
Research Site Brownsburg Indiana 46112
Research Site New Orleans Louisiana 70124
Research Site Troy Michigan 48085
Research Site Olive Branch Mississippi 38654
Research Site Brooklyn New York 11235
Research Site Columbus Ohio 43213
Research Site Edmond Oklahoma 73013
Research Site Austin Texas 78705
Research Site Carrollton Texas 75006
Research Site Dallas Texas 75234
Research Site Georgetown Texas 78628
Research Site Houston Texas 77040
Research Site Lampasas Texas 76550
Research Site San Antonio Texas 78209
Research Site West Valley City Utah 84120
Research Site Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05459688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2024 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05459688 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →